Fucoidan Inhibits the Growth of Hepatocellular Carcinoma Independent of Angiogenesis
Some sulphated polysaccharides can bind bFGF but are unable to present bFGF to its high-affinity receptors. Fucoidan, a sulphated polysaccharide purified from brown algae, which has been used as an anticancer drug in traditional Chinese medicine for hundreds of years, exhibits a variety of anticance...
Main Authors: | Cong Zhu, Rui Cao, Shuang-Xia Zhang, Ya-Nan Man, Xiong-Zhi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/692549 |
Similar Items
-
Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression
by: Danhui Ma, et al.
Published: (2021-04-01) -
NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
by: Wang Jianlong, et al.
Published: (2021-05-01) -
Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis
by: Shen Hu, et al.
Published: (2019-01-01) -
Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008-07-01) -
ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
by: Massimiliano Berretta, et al.
Published: (2016-11-01)